Compare VOR & ETHM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VOR | ETHM |
|---|---|---|
| Founded | 2015 | 2024 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 345.1M | 228.9M |
| IPO Year | 2021 | 2024 |
| Metric | VOR | ETHM |
|---|---|---|
| Price | $17.75 | $10.36 |
| Analyst Decision | Buy | |
| Analyst Count | 10 | 0 |
| Target Price | ★ $64.78 | N/A |
| AVG Volume (30 Days) | ★ 1.1M | 86.4K |
| Earning Date | 11-13-2025 | 03-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.62 | $9.79 |
| 52 Week High | $65.80 | $15.24 |
| Indicator | VOR | ETHM |
|---|---|---|
| Relative Strength Index (RSI) | 62.42 | N/A |
| Support Level | $13.00 | N/A |
| Resistance Level | $18.60 | N/A |
| Average True Range (ATR) | 1.66 | 0.00 |
| MACD | 0.55 | 0.00 |
| Stochastic Oscillator | 85.56 | 0.00 |
Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VCAR33, Tremcel and Myelodysplastic Syndrome, Trem-cel+VCAR33 Treatment System, VADC45, CD123, CLL1, EMR2.
Dynamix Corp is a blank check company.